digital currency in world, Featured

The new CEO of Pakistan Stock Exchange said that the exchange is seeking to provide traders with the option of cash settlement of futures trading, and plans to conduct a test before March next year.Musk: Grok can now generate four images at the same time and render them step by step.US media: Hamas may agree to temporarily stay in Gaza after the ceasefire of the Israeli army. On the 12th, the US media reported that the Palestinian Islamic Resistance Movement (Hamas) had softened its negotiating position and might agree to temporarily stay in Gaza after the ceasefire. Hamas has not yet responded to this news. (Xinhua News Agency)

Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.Contemporary Amperex Technology Co., Limited applied for the trademark of "Chargeo Charging Dog", and the intellectual property information of Tianyancha shows that recently, Contemporary Amperex Technology Co., Limited New Energy Technology Co., Ltd. applied for the registration of three trademarks of "Chargeo Charging Dog", which are internationally classified as transportation, scientific instruments and building repair, and the current trademark status is awaiting substantive examination. According to media reports, "CharGo charging dog" is a storage, charging and inspection integrated robot developed by Contemporary Amperex Technology Co., Limited. The charging dog has three functions in one. It is not only a mobile charging facility, but also a distributed energy storage, and it is also a battery safety guardian of new energy vehicles.Contemporary Amperex Technology Co., Limited applied for the trademark of "Chargeo Charging Dog", and the intellectual property information of Tianyancha shows that recently, Contemporary Amperex Technology Co., Limited New Energy Technology Co., Ltd. applied for the registration of three trademarks of "Chargeo Charging Dog", which are internationally classified as transportation, scientific instruments and building repair, and the current trademark status is awaiting substantive examination. According to media reports, "CharGo charging dog" is a storage, charging and inspection integrated robot developed by Contemporary Amperex Technology Co., Limited. The charging dog has three functions in one. It is not only a mobile charging facility, but also a distributed energy storage, and it is also a battery safety guardian of new energy vehicles.

Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.The cultural media sector rose and strengthened, with more than 10 daily limit shares, including Tianyu Digital, Guangbo, Palm Reading Technology, vision china, Huizhou Intelligent, Guangdong Media, Tianxiaxiu and Lingnan.